修订后的美国联合癌症委员会癌症分期系统的比较有效性
Chia-Wen Kao1, Chun-Ju Chiang1,2, Wen-Chung Lee1,2,3
1Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
American journal of epidemiology
|September 1, 2024
概括
美国癌症联合委员会 (AJCC) 第八版的分期手册提供了在台湾改善的癌症预后. 它更好地区分生存率和重新分类病例,以改善患者前景.
科学领域:
- 在瘤学瘤学.
- 癌症的分期 癌症的分期
- 流行病学 流行病学
背景情况:
- 美国癌症联合委员会 (AJCC) 的分期手册对于癌症的分类和预后至关重要.
- AJCC手册的定期更新旨在提高其准确性和临床实用性.
- 评估新版本对于了解它们对患者治疗结果的影响至关重要.
研究的目的:
- 评估台湾第七和第八届AJCC比赛的演出表现.
- 评估AJCC第7版和第8版之间的癌症病例重新分类.
- 分析第八版对特定阶段生存曲线和预后的影响.
主要方法:
- 利用来自台湾癌症登记处的数据,用于2017年 (7版) 和2018年 (8版) 诊断的癌症病例.
- 使用接收器运行特征曲线 (AUC) 下面的面积和基尼指数评估分阶段性能.
- 评估了对预后准确性的2年生存率,并比较了跨版本的重新分类.
主要成果:
- 第八届AJCC展现了四种特定癌症类型的优越分期性能.
- 在第八版下,口腔癌在各个阶段显示出更可变的生存率.
- 肝癌表现出更明显的存活率下降随着进展的阶段;非小细胞肺癌的预后得到改善.
- 第8版将26.4%的4期前列腺癌患者 (第7版) 重新分类为3或4A期,2年生存率>90%.
结论:
- 第八版AJCC提供了精细的特定阶段生存区分和改进的病例重新分类,以提高台湾的预后.
- 更新的手册显示,对于特定的癌症,如肝癌,口癌,非小细胞肺癌和前列腺癌,有显著的改善.
- 在采用新的AJCC分期版本时,建议进行彻底的评估,以确保最佳的临床应用.
相关概念视频
01:19Standards of Care II
638
Nurses bear specific legal responsibilities under several federal statutes, including:
638
01:21Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
01:22Standards of Care I
670
Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
670
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:20Comparing the Survival Analysis of Two or More Groups
162
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
162
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K